D. Flentje
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
-
- Bone health and osteoporosis research
Papers in
- Oncology 7
- Cancer Cells and Metastasis 3
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 2
- Bone health and treatments 2
-
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- P. Schlag (3 shared papers)Stefanie Fischer (4 shared papers)E. Blind (3 shared papers)H. Schmidt‐Gayk (2 shared papers)Walter Hitzler (2 shared papers)Stephan Scharla (1 shared paper)Stephen A. Sapareto (2 shared papers)H. J. Buhr (2 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Clinical Chemistry (1 paper)Cell Proliferation (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
D. Flentje
13 papers receiving 324 citations
Peers
Comparison fields: 5 of 72
- Nephrology 122
- Orthopedics and Sports Medicine 22
- Oncology 61
- Pharmacology 35
- Immunology 36
Countries citing papers authored by D. Flentje
This map shows the geographic impact of D. Flentje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Flentje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Flentje more than expected).
Fields of papers citing papers by D. Flentje
This network shows the impact of papers produced by D. Flentje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Flentje. The network helps show where D. Flentje may publish in the future.
Co-authors
The 22 scholars most cited alongside D. Flentje, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 128 | |
| 2 | 1988 | 91 | |
| 3 | 1990 | 27 | |
| 4 | Differential effect of hyperthermia on murine bone marrow normal colony-forming units and AKR and L1210 leukemia stem cells. | 1984 | 26 |
| 5 | 1990 | 24 | |
| 6 | 1983 | 19 | |
| 7 | 1989 | 5 | |
| 8 | 1986 | 5 | |
| 9 | 1984 | 4 | |
| 10 | Is chemosensitivity testing for peri-operative treatment planning in gastro-intestinal cancer by the human tumour colony assay worthwhile? | 1985 | 4 |
| 11 | 1987 | 2 | |
| 12 | 1984 | 2 | |
| 13 | [Clinical management of persistent primary hyperparathyroidism]. | 1990 | 1 |
About D. Flentje
D. Flentje is a scholar working on Oncology, Molecular Biology, Nephrology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 338 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (5 papers), Cancer Cells and Metastasis (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Genetic Syndromes and Imprinting (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Nephrology (122 citations), Orthopedics and Sports Medicine (22 citations), Oncology (61 citations), Pharmacology (35 citations) and Immunology (36 citations). D. Flentje has collaborated with scholars based in Germany and United States. Frequent co-authors include P. Schlag, Stefanie Fischer, E. Blind, H. Schmidt‐Gayk, Walter Hitzler, Stephan Scharla, Stephen A. Sapareto, H. J. Buhr, Gary Van Zant and H Schmidt-Gayk. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Chemistry, Cell Proliferation, The Journal of Clinical Endocrinology & Metabolism and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.